• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入高剂量鼠尾草叶大麻素A在人体中的药代动力学和激素效应的时间进程。

Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.

作者信息

Johnson Matthew W, MacLean Katherine A, Caspers Michael J, Prisinzano Thomas E, Griffiths Roland R

机构信息

Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

J Psychopharmacol. 2016 Apr;30(4):323-9. doi: 10.1177/0269881116629125. Epub 2016 Feb 15.

DOI:10.1177/0269881116629125
PMID:26880225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5289219/
Abstract

Salvinorin A is a kappa opioid agonist and the principal psychoactive constituent of the Salvia divinorum plant, which has been used for hallucinogenic effects. Previous research on salvinorin A pharmacokinetics likely underestimated plasma levels typically resulting from the doses administered due to inefficient vaporization and not collecting samples during peak drug effects. Six healthy adults inhaled a single high dose of vaporized salvinorin A (n = 4, 21 mcg/kg; n = 2, 18 mcg/kg). Participant- and monitor-rated effects were assessed every 2 min for 60 min post-inhalation. Blood samples were collected at 13 time points up to 90 min post-inhalation. Drug levels peaked at 2 min and then rapidly decreased. Drug levels were significantly, positively correlated with participant and monitor drug effect ratings. Significant elevations in prolactin were observed beginning 5 min post-inhalation and peaking at 15 min post-inhalation. Cortisol showed inconsistent increases across participants. Hormonal responses were not well correlated with drug levels. This is the first study to demonstrate a direct relationship between changes in plasma levels of salvinorin A and drug effects in humans. The results confirm the efficacy of an inhalation technique for salvinorin A.

摘要

萨尔维诺林A是一种κ阿片受体激动剂,也是鼠尾草植物的主要精神活性成分,该植物一直被用于产生致幻效果。先前关于萨尔维诺林A药代动力学的研究可能低估了通常因给药剂量而产生的血浆水平,这是由于汽化效率低下且未在药物效果峰值期间采集样本所致。六名健康成年人吸入了单次高剂量的汽化萨尔维诺林A(n = 4,21微克/千克;n = 2,18微克/千克)。吸入后60分钟内,每2分钟评估一次参与者和监测者评定的效果。在吸入后长达90分钟的13个时间点采集血样。药物水平在2分钟时达到峰值,然后迅速下降。药物水平与参与者和监测者的药物效果评定显著正相关。吸入后5分钟开始观察到催乳素显著升高,并在吸入后15分钟达到峰值。皮质醇在各参与者中呈现出不一致的升高。激素反应与药物水平相关性不佳。这是第一项证明人类血浆中萨尔维诺林A水平变化与药物效果之间存在直接关系的研究。结果证实了吸入技术对萨尔维诺林A的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/712701c894ed/nihms846341f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/af2d4e27344f/nihms846341f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/b7aecee9b411/nihms846341f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/be8bda5e3707/nihms846341f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/712701c894ed/nihms846341f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/af2d4e27344f/nihms846341f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/b7aecee9b411/nihms846341f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/be8bda5e3707/nihms846341f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c285/5289219/712701c894ed/nihms846341f4.jpg

相似文献

1
Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.吸入高剂量鼠尾草叶大麻素A在人体中的药代动力学和激素效应的时间进程。
J Psychopharmacol. 2016 Apr;30(4):323-9. doi: 10.1177/0269881116629125. Epub 2016 Feb 15.
2
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.人类精神药理学和 Salvinorin A 的剂量效应,Salvinorin A 是一种存在于植物 Salvia divinorum 中的 κ 阿片样物质激动剂致幻剂。
Drug Alcohol Depend. 2011 May 1;115(1-2):150-5. doi: 10.1016/j.drugalcdep.2010.11.005. Epub 2010 Dec 4.
3
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.人类体内与剂量相关的紫堇醇灵碱作用:分离性、致幻和记忆效应。
Psychopharmacology (Berl). 2013 Mar;226(2):381-92. doi: 10.1007/s00213-012-2912-9. Epub 2012 Nov 8.
4
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.舌下含服天然 κ 阿片受体激动剂萨维诺林 A 对人体无作用:一项安慰剂对照试验。
Psychopharmacology (Berl). 2011 Apr;214(4):933-9. doi: 10.1007/s00213-010-2103-5. Epub 2010 Dec 8.
5
Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.Salvinorin A是致幻鼠尾草(Salvia divinorum)的一种活性成分,是一种高效的κ-阿片受体激动剂:结构与功能方面的考量。
J Pharmacol Exp Ther. 2004 Mar;308(3):1197-203. doi: 10.1124/jpet.103.059394. Epub 2004 Jan 8.
6
The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.植物源性致幻剂——Salvinorin A在恒河猴身上产生κ-阿片受体激动剂样辨别效应。
Psychopharmacology (Berl). 2004 Mar;172(2):220-4. doi: 10.1007/s00213-003-1638-0. Epub 2003 Oct 30.
7
The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.从鼠尾草中提取的致幻剂——二萜内酯A,在大鼠中具有κ-阿片受体激动剂的辨别刺激效应。
Neuropharmacology. 2007 Sep;53(4):481-6. doi: 10.1016/j.neuropharm.2007.06.008. Epub 2007 Jun 27.
8
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates.植物源性κ-阿片类致幻剂Salvinorin A在非人灵长类动物中的药代动力学
Synapse. 2005 Dec 1;58(3):208-10. doi: 10.1002/syn.20191.
9
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.在人类中,κ 阿片样物质激动剂 Salvinorin A 的剂量相关的行为、主观、内分泌和心理生理效应。
Biol Psychiatry. 2012 Nov 15;72(10):871-9. doi: 10.1016/j.biopsych.2012.06.012. Epub 2012 Jul 18.
10
Acute and post-acute behavioral and psychological effects of salvinorin A in humans.人类体内阿片样物质 Salvinorin A 的急性和亚急性行为与心理效应。
Psychopharmacology (Berl). 2012 Mar;220(1):195-204. doi: 10.1007/s00213-011-2470-6. Epub 2011 Sep 8.

引用本文的文献

1
Pharmacokinetics and Pharmacodynamics of Salvinorin A and : Clinical and Forensic Aspects.鼠尾草叶大麻酚A的药代动力学与药效学:临床与法医学方面
Pharmaceuticals (Basel). 2021 Feb 3;14(2):116. doi: 10.3390/ph14020116.
2
Chemical syntheses of the salvinorin chemotype of KOR agonist.KOR 激动剂中 salvinorin 型的化学合成。
Nat Prod Rep. 2020 Nov 18;37(11):1478-1496. doi: 10.1039/d0np00028k.
3
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.

本文引用的文献

1
Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.Salvinorin-A会引发强烈的分离性效应,阻断外部感官知觉,并调节人体的内感受和身体自我认知感。
Int J Neuropsychopharmacol. 2015 Jun 5;18(12):pyv065. doi: 10.1093/ijnp/pyv065.
2
The subjective experience of acute, experimentally-induced Salvia divinorum inebriation.急性实验性诱导的鼠尾草醉酒的主观体验。
J Psychopharmacol. 2015 Apr;29(4):426-35. doi: 10.1177/0269881115570081. Epub 2015 Feb 17.
3
Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.
纳呋拉啡作为一种阿片类药物节约辅助药物的临床前测试,该药物通过靶向μ阿片受体的激动剂吗啡增强镇痛作用。
J Pharmacol Exp Ther. 2019 Nov;371(2):487-499. doi: 10.1124/jpet.118.255661. Epub 2019 Sep 6.
4
Modular Approach to pseudo-Neoclerodanes as Designer κ-Opioid Ligands.作为 κ-阿片受体配体的拟新石松烷的模块化方法。
Org Lett. 2017 Oct 6;19(19):5414-5417. doi: 10.1021/acs.orglett.7b02684. Epub 2017 Sep 14.
5
Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization.Salvinorin A抑制卵清蛋白致敏诱导的气道高反应性。
Front Pharmacol. 2017 Jan 13;7:525. doi: 10.3389/fphar.2016.00525. eCollection 2016.
6
Clinical applications of hallucinogens: A review.致幻剂的临床应用:综述
Exp Clin Psychopharmacol. 2016 Aug;24(4):229-68. doi: 10.1037/pha0000084.
7
Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.纳曲酮而非酮色林可拮抗鼠尾草酚对人体的主观、心血管及神经内分泌效应。
Int J Neuropsychopharmacol. 2016 Jul 5;19(7). doi: 10.1093/ijnp/pyw016. Print 2016 Jul.
新型滥用药物:不断演变的市场概况
Adolesc Psychiatry (Hilversum). 2013 Apr;3(2):123-134. doi: 10.2174/2210676611303020003.
4
LC-MS/MS quantification of salvinorin A from biological fluids.生物流体中萨尔维诺灵A的液相色谱-串联质谱定量分析。
Anal Methods. 2013 Dec 21;5(24). doi: 10.1039/C3AY40810H.
5
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.人类体内与剂量相关的紫堇醇灵碱作用:分离性、致幻和记忆效应。
Psychopharmacology (Berl). 2013 Mar;226(2):381-92. doi: 10.1007/s00213-012-2912-9. Epub 2012 Nov 8.
6
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.在人类中,κ 阿片样物质激动剂 Salvinorin A 的剂量相关的行为、主观、内分泌和心理生理效应。
Biol Psychiatry. 2012 Nov 15;72(10):871-9. doi: 10.1016/j.biopsych.2012.06.012. Epub 2012 Jul 18.
7
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.内啡肽/κ-阿片受体系统及其在精神疾病中的作用。
Cell Mol Life Sci. 2012 Mar;69(6):857-96. doi: 10.1007/s00018-011-0844-x. Epub 2011 Oct 16.
8
Acute and post-acute behavioral and psychological effects of salvinorin A in humans.人类体内阿片样物质 Salvinorin A 的急性和亚急性行为与心理效应。
Psychopharmacology (Berl). 2012 Mar;220(1):195-204. doi: 10.1007/s00213-011-2470-6. Epub 2011 Sep 8.
9
Use of Salvia divinorum in a nationally representative sample.使用迷幻鼠尾草的全国代表性样本。
Am J Drug Alcohol Abuse. 2012 Jan;38(1):108-13. doi: 10.3109/00952990.2011.600397. Epub 2011 Aug 11.
10
Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers.近期与非使用者相比,近期及既往使用鼠尾草者中鼠尾草使用及物质使用障碍的全国趋势。
Subst Abuse Rehabil. 2011 Apr;2011(2):53-68. doi: 10.2147/SAR.S17192.